• Nature

COVID-19 vigilance

Updated: Dec 7, 2020

Clinical trials of four vaccine candidates are showing remarkable promise, with three exceeding 90% efficacy, no safety concerns and one has shown promise in older adults.

COVAX, a global alliance seeking to ensure that low- and middle-income countries get adequate vaccine provision, has only been able to secure vaccines for around 250 million people — far below what is needed.

Importantly, AstraZeneca and Oxford have pledged to provide their vaccine at cost price to all during the pandemic, and to maintain this price for low- and middle-income countries after the pandemic, when a vaccine will still be needed in case of future outbreaks. As infectious-disease researchers often say, an outbreak anywhere is an outbreak everywhere. Read more ...

Wear a mask, social distance, wash your hands, and get the vaccine (Facebook is now taking down misinformation on vaccines). See IATA to monitor international travel restrictions, and Commonwealth Innovation for Commonwealth country COVID performance.

1 view0 comments

Recent Posts

See All

Happy Holidays - 2020

As we enter the holiday season, the Board of Directors of the Royal Commonwealth Society Ottawa reflects on the year that was 2020. As a registered education charity we: ESTABLISH BURSARIES for Common

Commonwealth Youth Profile - Aniqah Zowmi

Canadian Aniqah Zowmi brings expertise and passion for helping governments and civic organisations embrace equality and diversity and achieve full inclusion at levels. She is currently the director of

RCS Ottawa

Basil Crozier - Chair


© 2020 By Royal Commonwealth Society Ottawa  Charity# 119128916RR0001

established 1968